For individuals undergoing allergy immunotherapy, the DA Form 5007A serves as a crucial element in tracking the progress and reactions to each treatment phase. This documentation, detailed by the Army Regulation 40-66, is meticulously designed to ensure the comprehensive monitoring of each immunotherapy session. It encompasses the entire spectrum of the treatment process from the type of extract used, the shot date, and when the next evaluation is due, to more specific information such as prescription numbers, extract content, and any history of systemic reactions. Furthermore, the form assesses patient safety by inquiring about beta blocker usage, a critical consideration for allergen immunotherapy. The use of this form extends to recording the vial number, the strength of the dose, the dosing schedule, the administered dose, and which arm was used, alongside any reactions or special instructions noted by the healthcare technicians. This detailed approach aims at creating a systematic record-keeping method that enhances the quality of care for individuals receiving allergy shots. Essential details such as the patient's identification, including name, social security number, date of birth, and the treating facility, are also standardized within this form to ensure clarity and efficiency in managing medical records. This form represents a key tool in the arsenal of healthcare providers, giving them the ability to closely monitor patients' progression and tailor treatments to their specific allergenic needs.
Question | Answer |
---|---|
Form Name | Da Form 5007A |
Form Length | 1 pages |
Fillable? | No |
Fillable fields | 0 |
Avg. time to fill out | 15 sec |
Other names | 2003, 5007A, YYYYMMDD, v1 |
MEDICAL RECORD |
|
ALLERGY IMMUNOTHERAPY RECORD |
SINGLE |
||||||||||||
|
For use of this form, see AR |
EXTRACT |
|||||||||||||
START ALLERGY SHOT DATE |
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
||||
PRESCRIPTION NUMBER |
|
|
|
|
|
|
EXTRACT CONTENT |
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|||||||
HISTORY OF SYSTEMIC SHOT REACTIONS? |
YES |
|
ON BETA BLOCKERS? |
YES |
NO |
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DATE |
TIME |
VIAL # |
|
STRENGTH |
|
SCHEDULE |
DOSE |
ARM |
REACTIONS OR SPECIAL INSTRUCTIONS |
TECH |
|||||
(YYYYMMDD) |
(pnu/ml, wt/vol, AU/ml) |
|
A, B, C, D, E, F |
(ml) |
INITIALS |
||||||||||
|
|
|
|
|
|
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PATIENT'S IDENTIFICATION |
(For typed or written entries give |
|
|
|
NURSING PERSONNEL INITIALS |
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
NAME |
|
|
INITIALS |
NAME |
|
INITIALS |
|||||
|
|
SSN; DOB; sex; treating facility) |
|
|
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DA FORM 5007A, FEB 2003
DA FORM |
APD PE v1.02ES |